Orthobiologics Market by Product (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End - User (Hospitals, Orthopedic Clinics) - Global Forecast to 2019
The global orthobiologics market is estimated to grow at a CAGR of 6.7% from 2014 to 2019.
The end-user segment of this market is classified into hospitals, orthopedic clinics, and other end-users. Rise in cases of road accidents, as well as increasing awareness among patients with regards to the benefits associated with orthobiologics products are propelling the growth of orthobiologics market. The companies operating in this market have been stressing on new product developments, and mergers and acquisitions in order to establish their position in this highly competitive market.
The report has profiled leading players of this market along with recent developments (new product launches and partnerships, mergers and acquisitions, and joint ventures) and growth strategies adopted by them to sustain their position in the global orthobiologics market. Major players of the global orthobiologics market are Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), DePuy Synthes (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.).
Reasons to Buy the Report:
This comprehensive research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which constitute basic views on the competitive landscape, usage patterns, emerging and high-growth segments of the orthobiologics market, high-growth regions and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to verify the current market conditions which in turn will help firms garner a greater market share. Firms purchasing the report could use any one or a customized combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
The end-user segment of this market is classified into hospitals, orthopedic clinics, and other end-users. Rise in cases of road accidents, as well as increasing awareness among patients with regards to the benefits associated with orthobiologics products are propelling the growth of orthobiologics market. The companies operating in this market have been stressing on new product developments, and mergers and acquisitions in order to establish their position in this highly competitive market.
The report has profiled leading players of this market along with recent developments (new product launches and partnerships, mergers and acquisitions, and joint ventures) and growth strategies adopted by them to sustain their position in the global orthobiologics market. Major players of the global orthobiologics market are Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), DePuy Synthes (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.).
Reasons to Buy the Report:
This comprehensive research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which constitute basic views on the competitive landscape, usage patterns, emerging and high-growth segments of the orthobiologics market, high-growth regions and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to verify the current market conditions which in turn will help firms garner a greater market share. Firms purchasing the report could use any one or a customized combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
- Product Analysis and development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the orthobiologics market. Usage pattern/ penetration rate (in-depth trend analysis) of products (Segment wise) and purchasing data. Comprehensive coverage of product approvals and product recalls.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for orthobiologics across geographies so as to exploit new clientele base and different pricing policies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the orthobiologics market. Detailed description regarding the related and unrelated diversification pertaining to this market
- Competitive Assessment: In-depth assessment of market shares, company share analysis of the key players forecasted till 2019. Develop business strategies and manufacturing capabilities of leading players in order to enhance the bottom line of the companies in the orthobiologics market
- Product/ Brand Perception Analysis: Comprehensive study of customer perception and behavior through our inbuilt social connect tools (digital marketing language) and checking the tenacity of blogs and social forums
1 INTRODCTION
1.1 OBJECTIVES OF THE STDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF ORTHOBIOLOGICS MARKET
2.1.1 TOP-DOWN APPROACH
2.1.2 BOTTOM-P APPROACH
2.1.3 MACROINDICATOR-BASED APPROACH
2.2 ASSMPTIONS
3 EXECTIVE SMMARY
4 MARKET OVERVIEW
4.1 INTRODCTION
4.2 MARKET DRIVERS AND INHIBITORS
4.3 KEY MARKET DYNAMICS
5 ORTHOBIOLOGICS MARKET, BY PRODCT
5.1 INTRODCTION
5.2 GLOBAL ORTHOBIOLOGICS MARKET: PRODCT COMPARISON WITH PARENT MARKET
5.3 GLOBAL BONE GRAFT SBSTITTES MARKET, BY GEOGRAPHY
5.4 GLOBAL BONE ALLOGRAFTS MARKET, BY GEOGRAPHY
5.5 GLOBAL STEM CELL THERAPY MARKET, BY GEOGRAPHY
5.6 GLOBAL BONE GROWTH FACTOR AND SPINAL STIMLATION MARKET, BY GEOGRAPHY
5.7 GLOBAL VISCOSPPLEMENTATION MARKET, BY GEOGRAPHY
6 ORTHOBIOLOGICS MARKET, BY END-SER
6.1 INTRODCTION
6.2 GLOBAL ORTHOBIOLOGICS MARKET HOSPITALS MARKET, BY GEOGRAPHY
6.3 GLOBAL ORTHOPEDIC CLINICS MARKET, BY GEOGRAPHY
6.4 GLOBAL ORTHOBIOLOGICS OTHER END-SERS MARKET, BY GEOGRAPHY
7 ORTHOBIOLOGICS MARKET, BY GEOGRAPHY
7.1 INTRODCTION
7.2 NORTH AMERICA ORTHOBIOLOGICS MARKET
7.2.1 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY PRODCT
7.2.2 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY END-SER
7.3 EROPE ORTHOBIOLOGICS MARKET
7.3.1 EROPE ORTHOBIOLOGICS MARKET, BY PRODCT
7.3.2 EROPE ORTHOBIOLOGICS MARKET, BY END-SER
7.4 ASIA ORTHOBIOLOGICS MARKET
7.4.1 ASIA ORTHOBIOLOGICS MARKET, BY PRODCT
7.4.2 ASIA ORTHOBIOLOGICS MARKET, BY END-SER
7.5 REST OF THE WORLD (ROW) ORTHOBIOLOGICS MARKET
7.5.1 ROW ORTHOBIOLOGICS MARKET, BY PRODCT
7.5.2 ROW ORTHOBIOLOGICS MARKET, BY END-SER
8 ORTHOBIOLOGICS MARKET: COMPETITIVE LANDSCAPE
8.1 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS
8.2 COMPANY PRESENCE IN ORTHOBIOLOGICS MARKET, BY PRODCT
8.3 MERGERS & ACQISITIONS
8.4 NEW PRODCT LANCHES
8.5 EXPANSIONS
8.6 AGREEMENTS
8.7 OTHER DEVELOPMENTS
9 ORTHOBIOLOGICS MARKET, BY COMPANY
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 BIOMET, INC.
9.2 MEDTRONIC PLC
9.3 INTEGRA LIFE SCIENCES CORPORATION
9.4 STRYKER CORPORATION
9.5 ZIMMER, INC.
9.6 DEPY SYNTHES (JOHNSON & JOHNSON FAMILY OF COMPANIES)
9.7 TORNIER, INC.
9.8 NVASIVE, INC.
9.9 EXACTECH, INC.
9.10 GLOBS MEDICAL INC.
9.11 WRIGHT MEDICAL TECHNOLOGY, INC.
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
10 APPENDIX
10.1 CSTOMIZATION OPTIONS
10.1.1 REGLATORY FRAMEWORK
10.1.2 EPIDEMIOLOGY DATA
10.1.3 SRGEONS/PHYSICIANS PERCEPTION ANALYSIS
10.1.4 IMPACT ANALYSIS
10.2 RELATED REPORTS
10.3 INTRODCING RT: REAL TIME MARKET INTELLIGENCE
10.3.1 RT SNAPSHOTS
1.1 OBJECTIVES OF THE STDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF ORTHOBIOLOGICS MARKET
2.1.1 TOP-DOWN APPROACH
2.1.2 BOTTOM-P APPROACH
2.1.3 MACROINDICATOR-BASED APPROACH
2.2 ASSMPTIONS
3 EXECTIVE SMMARY
4 MARKET OVERVIEW
4.1 INTRODCTION
4.2 MARKET DRIVERS AND INHIBITORS
4.3 KEY MARKET DYNAMICS
5 ORTHOBIOLOGICS MARKET, BY PRODCT
5.1 INTRODCTION
5.2 GLOBAL ORTHOBIOLOGICS MARKET: PRODCT COMPARISON WITH PARENT MARKET
5.3 GLOBAL BONE GRAFT SBSTITTES MARKET, BY GEOGRAPHY
5.4 GLOBAL BONE ALLOGRAFTS MARKET, BY GEOGRAPHY
5.5 GLOBAL STEM CELL THERAPY MARKET, BY GEOGRAPHY
5.6 GLOBAL BONE GROWTH FACTOR AND SPINAL STIMLATION MARKET, BY GEOGRAPHY
5.7 GLOBAL VISCOSPPLEMENTATION MARKET, BY GEOGRAPHY
6 ORTHOBIOLOGICS MARKET, BY END-SER
6.1 INTRODCTION
6.2 GLOBAL ORTHOBIOLOGICS MARKET HOSPITALS MARKET, BY GEOGRAPHY
6.3 GLOBAL ORTHOPEDIC CLINICS MARKET, BY GEOGRAPHY
6.4 GLOBAL ORTHOBIOLOGICS OTHER END-SERS MARKET, BY GEOGRAPHY
7 ORTHOBIOLOGICS MARKET, BY GEOGRAPHY
7.1 INTRODCTION
7.2 NORTH AMERICA ORTHOBIOLOGICS MARKET
7.2.1 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY PRODCT
7.2.2 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY END-SER
7.3 EROPE ORTHOBIOLOGICS MARKET
7.3.1 EROPE ORTHOBIOLOGICS MARKET, BY PRODCT
7.3.2 EROPE ORTHOBIOLOGICS MARKET, BY END-SER
7.4 ASIA ORTHOBIOLOGICS MARKET
7.4.1 ASIA ORTHOBIOLOGICS MARKET, BY PRODCT
7.4.2 ASIA ORTHOBIOLOGICS MARKET, BY END-SER
7.5 REST OF THE WORLD (ROW) ORTHOBIOLOGICS MARKET
7.5.1 ROW ORTHOBIOLOGICS MARKET, BY PRODCT
7.5.2 ROW ORTHOBIOLOGICS MARKET, BY END-SER
8 ORTHOBIOLOGICS MARKET: COMPETITIVE LANDSCAPE
8.1 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS
8.2 COMPANY PRESENCE IN ORTHOBIOLOGICS MARKET, BY PRODCT
8.3 MERGERS & ACQISITIONS
8.4 NEW PRODCT LANCHES
8.5 EXPANSIONS
8.6 AGREEMENTS
8.7 OTHER DEVELOPMENTS
9 ORTHOBIOLOGICS MARKET, BY COMPANY
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 BIOMET, INC.
9.2 MEDTRONIC PLC
9.3 INTEGRA LIFE SCIENCES CORPORATION
9.4 STRYKER CORPORATION
9.5 ZIMMER, INC.
9.6 DEPY SYNTHES (JOHNSON & JOHNSON FAMILY OF COMPANIES)
9.7 TORNIER, INC.
9.8 NVASIVE, INC.
9.9 EXACTECH, INC.
9.10 GLOBS MEDICAL INC.
9.11 WRIGHT MEDICAL TECHNOLOGY, INC.
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
10 APPENDIX
10.1 CSTOMIZATION OPTIONS
10.1.1 REGLATORY FRAMEWORK
10.1.2 EPIDEMIOLOGY DATA
10.1.3 SRGEONS/PHYSICIANS PERCEPTION ANALYSIS
10.1.4 IMPACT ANALYSIS
10.2 RELATED REPORTS
10.3 INTRODCING RT: REAL TIME MARKET INTELLIGENCE
10.3.1 RT SNAPSHOTS
LIST OF TABLES
Table 1 GLOBAL ORTHOBIOLOGICS PEER MARKET SIZE, 2014 (SD MN)
Table 2 GLOBAL ORTHOBIOLOGICS MARKET: MACROINDICATOR, BY CONTRY, 2014
Table 3 GLOBAL ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET, 2013-2019 (SD MN)
Table 4 GLOBAL ORTHOBIOLOGICS MARKET: DRIVERS AND INHIBITORS
Table 5 GLOBAL ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Table 6 GLOBAL ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Table 7 GLOBAL ORTHOBIOLOGICS MARKET, PRODCT COMPARISON WITH PARENT MARKET, 2013–2019 (SD MN)
Table 8 GLOBAL BONE GRAFT SBSTITTES MARKET, BY GEOGRAPHY, 2013–2019 (SD MN)
Table 9 GLOBAL BONE ALLOGRAFTS MARKET, BY GEOGRAPHY, 2013-2019 (SD MN)
Table 10 GLOBAL STEM CELL THERAPY MARKET, BY GEOGRAPHY, 2013-2019 (SD MN)
Table 11 GLOBAL STEM CELL THERAPY MARKET, BY GEOGRAPHY, 2013-2019 (SD MN)
Table 12 GLOBAL VISCOSPPLEMENTATION MARKET, BY GEOGRAPHY, 2013–2019 (SD MN)
Table 13 GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END-SER, 2013-2019 (SD MN)
Table 14 GLOBAL ORTHOBIOLOGICS MARKET IN HOSPITALS, BY GEOGRAPHY, 2013-2019 (SD MN)
Table 15 GLOBAL ORTHOPEDIC MARKET IN CLINICS, BY GEOGRAPHY, 2013-2019 (SD MN)
Table 16 GLOBAL ORTHOBIOLOGICS MARKET IN OTHER END-SERS, BY GEOGRAPHY, 2013 - 2019 (SD MN)
Table 17 GLOBAL ORTHOBIOLOGICS MARKET, BY GEOGRAPHY, 2013-2019 (SD MN)
Table 18 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Table 19 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Table 20 EROPE ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Table 21 EROPE ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Table 22 ASIA ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Table 23 ASIA ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Table 24 ROW ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Table 25 ROW ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Table 26 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2013 (%)
Table 27 GLOBAL ORTHOBIOLOGICS MARKET: MERGERS & ACQISITIONS
Table 28 GLOBAL ORTHOBIOLOGICS MARKET: NEW PRODCT LANCHES
Table 29 GLOBAL ORTHOBIOLOGICS MARKET: EXPANSIONS
Table 30 GLOBAL ORTHOBIOLOGICS MARKET: AGREEMENTS
Table 31 GLOBAL ORTHOBIOLOGICS MARKET: OTHER DEVELOPMENTS
Table 32 BIOMET, INC.: KEY FINANCIALS, 2011-2013 (SD MN)
Table 33 MEDTRONIC, PLC.: KEY FINANCIALS, 2009-2013 (SD MN)
Table 34 INTEGRA LIFE SCIENCES CORPORATION: KEY FINANCIALS, 2010-2013 (SD MN)
Table 35 STRYKER CORPORATION: KEY FINANCIALS, 2009-2013 (SD MN)
Table 36 ZIMMER, INC.: KEY FINANCIALS, 2009-2013 (SD MN)
Table 37 DEPY SYNTHES: KEY FINANCIALS, 2011-2013 (SD MN)
Table 38 TORNIER, INC.: KEY FINANCIALS, 2009-2013 (SD MN)
Table 39 NVASIVE, INC.: KEY FINANCIALS, 2009-2013 (SD MN)
Table 40 EXACTECH, INC.: KEY FINANCIALS, 2009-2013 (SD MN)
Table 41 GLOBS MEDICAL, INC.: KEY FINANCIALS, 2009-2013 (SD MN)
Table 42 WRIGHT MEDICAL TECHNOLOGY, INC.: KEY FINANCIALS, 2011-2013 (SD MN)
LIST OF FIGRES
Figure 1 GLOBAL ORTHOBIOLOGICS MARKET: SEGMENTATION & COVERAGE
Figure 2 ORTHOBIOLOGICS MARKET: INTEGRATED ECOSYSTEM
Figure 3 TOP-DOWN APPROACH
Figure 4 BOTTOM-P APPROACH
Figure 5 MACROINDICATOR-BASED APPROACH
Figure 6 GLOBAL ORTHOBIOLOGICS MARKET SNAPSHOT
Figure 7 GLOBAL ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET
Figure 8 GLOBAL ORTHOBIOLOGICS PRODCTS, BY GEOGRAPHY, 2014 (SD MN)
Figure 9 GLOBAL ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Figure 10 GLOBAL ORTHOBIOLOGICS MARKET: PRODCT COMPARISON WITH PARENT MARKET, 2013–2019 (SD MN)
Figure 11 GLOBAL BONE GRAFT SBSTITTES MARKET, BY GEOGRAPHY, 2013–2019 (SD MN)
Figure 12 GLOBAL BONE ALLOGRAFTS MARKET, BY GEOGRAPHY, 2013 - 2019 (SD MN)
Figure 13 GLOBAL STEM CELL THERAPY MARKET, BY GEOGRAPHY, 2013-2019 (SD MN)
Figure 14 GLOBAL BONE GROWTH FACTOR AND SPINAL STIMLATION MARKET, BY GEOGRAPHY, 2013-2019 (SD MN)
Figure 15 GLOBAL VISCOSPPLEMENTATION MARKET, BY GEOGRAPHY, 2013–2019 (SD MN)
Figure 16 GLOBAL ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Figure 17 GLOBAL ORTHOBIOLOGICS MARKET IN HOSPITALS, BY GEOGRAPHY, 2013-2019 (SD MN)
Figure 18 GLOBAL ORTHOPEDIC MARKET IN CLINICS, BY GEOGRAPHY, 2013-2019 (SD MN)
Figure 19 GLOBAL ORTHOBIOLOGICS MARKET IN OTHER END-SERS, BY GEOGRAPHY, 2013-2019 (SD MN)
Figure 20 GLOBAL ORTHOBIOLOGICS MARKET GROWTH ANALYSIS, BY GEOGRAPHY, 2014-2019 (SD MN)
Figure 21 NORTH AMERICA ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
Figure 22 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Figure 23 NORTH AMERICA: ORTHOBIOLOGICS MARKET: PRODCT SNAPSHOT
Figure 24 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Figure 25 NORTH AMERICA ORTHOBIOLOGICS MARKET: END-SER SNAPSHOT (%)
Figure 26 EROPE ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
Figure 27 EROPE ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Figure 28 EROPE ORTHOBIOLOGICS MARKET: PRODCT SNAPSHOT
Figure 29 EROPE ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Figure 30 EROPE: ORTHOBIOLOGICS MARKET: END-SER SNAPSHOT
Figure 31 ASIA ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
Figure 32 ASIA ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Figure 33 ASIA ORTHOBIOLOGICS MARKET: PRODCT SNAPSHOT
Figure 34 ASIA ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Figure 35 ASIA ORTHOBIOLOGICS MARKET: END-SER SNAPSHOT
Figure 36 ROW ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
Figure 37 ROW ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Figure 38 ROW ORTHOBIOLOGICS MARKET: PRODCT SNAPSHOT
Figure 39 ROW ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Figure 40 ROW ORTHOBIOLOGICS MARKET: END-SER SNAPSHOT
Figure 41 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Figure 42 ORTHOBIOLOGICS: COMPANY PRODCT COVERAGE, 2013
Figure 43 BIOMET, INC.: REVENE MIX, 2013 (%)
Figure 44 CONTRIBTION OF SPINE, BONE HEALING, AND MICROFIXATION SEGMENT TOWARDS COMPANY REVENES, 2011-2013 (SD MN)
Figure 45 MEDTRONIC, PLC. REVENE MIX, 2013 (%)
Figure 46 CONTRIBTION OF RESTORATIVE THERAPIES GROP SEGMENT TOWARDS COMPANY REVENES, 2009-2013 (SD MN)
Figure 47 INTEGRA LIFE SCIENCES CORPORATION REVENE MIX, 2013 (%)
Figure 48 CONTRIBTION OF U.S. SPINE AND OTHER SEGMENT TOWARDS COMPANY REVENES, 2010-2013 (SD MN)
Figure 49 STRYKER CORPORATION REVENE MIX, 2013 (%)
Figure 50 CONTRIBTION OF NEROTECHNOLOGY AND SPINE SEGMENT TOWARDS COMPANY REVENES, 2009-2013 (SD MN)
Figure 51 ZIMMER, INC.: REVENE MIX, 2013 (%)
Figure 52 CONTRIBTION OF SRGICAL AND OTHER SEGMENT TOWARDS COMPANY REVENES, 2009-2013 (SD MN)
Figure 53 DEPY SYNTHES REVENE MIX, 2013 (%)
Figure 54 TORNIER, INC.: REVENE MIX 2013 (%)
Figure 55 CONTRIBTION OF EXTREMITIES SEGMENT TOWARDS COMPANY REVENES, 2009-2013 (SD MN)
Figure 56 NVASIVE, INC.: REVENE MIX 2013 (%)
Figure 57 CONTRIBTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENES, 2009 - 2013 (SD MN)
Figure 58 EXACTECH, INC.: REVENE MIX 2013 (%)
Figure 59 CONTRIBTION OF BIOLOGICS & SPINE SEGMENT TOWARDS COMPANY REVENES, 2009-2013 (SD MN)
Figure 60 GLOBS MEDICAL, INC.: REVENE MIX 2013 (%)
Figure 61 CONTRIBTION OF DISRPTIVE TECHNOLOGY SEGMENT TOWARDS COMPANY REVENES, 2009-2013 (SD MN)
Figure 62 WRIGHT MEDICAL TECHNOLOGY, INC.: REVENE MIX 2013 (%)
Figure 63 CONTRIBTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENES, 2011 - 2013 (SD MN)
Table 1 GLOBAL ORTHOBIOLOGICS PEER MARKET SIZE, 2014 (SD MN)
Table 2 GLOBAL ORTHOBIOLOGICS MARKET: MACROINDICATOR, BY CONTRY, 2014
Table 3 GLOBAL ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET, 2013-2019 (SD MN)
Table 4 GLOBAL ORTHOBIOLOGICS MARKET: DRIVERS AND INHIBITORS
Table 5 GLOBAL ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Table 6 GLOBAL ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Table 7 GLOBAL ORTHOBIOLOGICS MARKET, PRODCT COMPARISON WITH PARENT MARKET, 2013–2019 (SD MN)
Table 8 GLOBAL BONE GRAFT SBSTITTES MARKET, BY GEOGRAPHY, 2013–2019 (SD MN)
Table 9 GLOBAL BONE ALLOGRAFTS MARKET, BY GEOGRAPHY, 2013-2019 (SD MN)
Table 10 GLOBAL STEM CELL THERAPY MARKET, BY GEOGRAPHY, 2013-2019 (SD MN)
Table 11 GLOBAL STEM CELL THERAPY MARKET, BY GEOGRAPHY, 2013-2019 (SD MN)
Table 12 GLOBAL VISCOSPPLEMENTATION MARKET, BY GEOGRAPHY, 2013–2019 (SD MN)
Table 13 GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END-SER, 2013-2019 (SD MN)
Table 14 GLOBAL ORTHOBIOLOGICS MARKET IN HOSPITALS, BY GEOGRAPHY, 2013-2019 (SD MN)
Table 15 GLOBAL ORTHOPEDIC MARKET IN CLINICS, BY GEOGRAPHY, 2013-2019 (SD MN)
Table 16 GLOBAL ORTHOBIOLOGICS MARKET IN OTHER END-SERS, BY GEOGRAPHY, 2013 - 2019 (SD MN)
Table 17 GLOBAL ORTHOBIOLOGICS MARKET, BY GEOGRAPHY, 2013-2019 (SD MN)
Table 18 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Table 19 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Table 20 EROPE ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Table 21 EROPE ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Table 22 ASIA ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Table 23 ASIA ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Table 24 ROW ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Table 25 ROW ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Table 26 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2013 (%)
Table 27 GLOBAL ORTHOBIOLOGICS MARKET: MERGERS & ACQISITIONS
Table 28 GLOBAL ORTHOBIOLOGICS MARKET: NEW PRODCT LANCHES
Table 29 GLOBAL ORTHOBIOLOGICS MARKET: EXPANSIONS
Table 30 GLOBAL ORTHOBIOLOGICS MARKET: AGREEMENTS
Table 31 GLOBAL ORTHOBIOLOGICS MARKET: OTHER DEVELOPMENTS
Table 32 BIOMET, INC.: KEY FINANCIALS, 2011-2013 (SD MN)
Table 33 MEDTRONIC, PLC.: KEY FINANCIALS, 2009-2013 (SD MN)
Table 34 INTEGRA LIFE SCIENCES CORPORATION: KEY FINANCIALS, 2010-2013 (SD MN)
Table 35 STRYKER CORPORATION: KEY FINANCIALS, 2009-2013 (SD MN)
Table 36 ZIMMER, INC.: KEY FINANCIALS, 2009-2013 (SD MN)
Table 37 DEPY SYNTHES: KEY FINANCIALS, 2011-2013 (SD MN)
Table 38 TORNIER, INC.: KEY FINANCIALS, 2009-2013 (SD MN)
Table 39 NVASIVE, INC.: KEY FINANCIALS, 2009-2013 (SD MN)
Table 40 EXACTECH, INC.: KEY FINANCIALS, 2009-2013 (SD MN)
Table 41 GLOBS MEDICAL, INC.: KEY FINANCIALS, 2009-2013 (SD MN)
Table 42 WRIGHT MEDICAL TECHNOLOGY, INC.: KEY FINANCIALS, 2011-2013 (SD MN)
LIST OF FIGRES
Figure 1 GLOBAL ORTHOBIOLOGICS MARKET: SEGMENTATION & COVERAGE
Figure 2 ORTHOBIOLOGICS MARKET: INTEGRATED ECOSYSTEM
Figure 3 TOP-DOWN APPROACH
Figure 4 BOTTOM-P APPROACH
Figure 5 MACROINDICATOR-BASED APPROACH
Figure 6 GLOBAL ORTHOBIOLOGICS MARKET SNAPSHOT
Figure 7 GLOBAL ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET
Figure 8 GLOBAL ORTHOBIOLOGICS PRODCTS, BY GEOGRAPHY, 2014 (SD MN)
Figure 9 GLOBAL ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Figure 10 GLOBAL ORTHOBIOLOGICS MARKET: PRODCT COMPARISON WITH PARENT MARKET, 2013–2019 (SD MN)
Figure 11 GLOBAL BONE GRAFT SBSTITTES MARKET, BY GEOGRAPHY, 2013–2019 (SD MN)
Figure 12 GLOBAL BONE ALLOGRAFTS MARKET, BY GEOGRAPHY, 2013 - 2019 (SD MN)
Figure 13 GLOBAL STEM CELL THERAPY MARKET, BY GEOGRAPHY, 2013-2019 (SD MN)
Figure 14 GLOBAL BONE GROWTH FACTOR AND SPINAL STIMLATION MARKET, BY GEOGRAPHY, 2013-2019 (SD MN)
Figure 15 GLOBAL VISCOSPPLEMENTATION MARKET, BY GEOGRAPHY, 2013–2019 (SD MN)
Figure 16 GLOBAL ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Figure 17 GLOBAL ORTHOBIOLOGICS MARKET IN HOSPITALS, BY GEOGRAPHY, 2013-2019 (SD MN)
Figure 18 GLOBAL ORTHOPEDIC MARKET IN CLINICS, BY GEOGRAPHY, 2013-2019 (SD MN)
Figure 19 GLOBAL ORTHOBIOLOGICS MARKET IN OTHER END-SERS, BY GEOGRAPHY, 2013-2019 (SD MN)
Figure 20 GLOBAL ORTHOBIOLOGICS MARKET GROWTH ANALYSIS, BY GEOGRAPHY, 2014-2019 (SD MN)
Figure 21 NORTH AMERICA ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
Figure 22 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Figure 23 NORTH AMERICA: ORTHOBIOLOGICS MARKET: PRODCT SNAPSHOT
Figure 24 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Figure 25 NORTH AMERICA ORTHOBIOLOGICS MARKET: END-SER SNAPSHOT (%)
Figure 26 EROPE ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
Figure 27 EROPE ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Figure 28 EROPE ORTHOBIOLOGICS MARKET: PRODCT SNAPSHOT
Figure 29 EROPE ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Figure 30 EROPE: ORTHOBIOLOGICS MARKET: END-SER SNAPSHOT
Figure 31 ASIA ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
Figure 32 ASIA ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Figure 33 ASIA ORTHOBIOLOGICS MARKET: PRODCT SNAPSHOT
Figure 34 ASIA ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Figure 35 ASIA ORTHOBIOLOGICS MARKET: END-SER SNAPSHOT
Figure 36 ROW ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
Figure 37 ROW ORTHOBIOLOGICS MARKET, BY PRODCT, 2013-2019 (SD MN)
Figure 38 ROW ORTHOBIOLOGICS MARKET: PRODCT SNAPSHOT
Figure 39 ROW ORTHOBIOLOGICS MARKET, BY END-SER, 2013-2019 (SD MN)
Figure 40 ROW ORTHOBIOLOGICS MARKET: END-SER SNAPSHOT
Figure 41 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Figure 42 ORTHOBIOLOGICS: COMPANY PRODCT COVERAGE, 2013
Figure 43 BIOMET, INC.: REVENE MIX, 2013 (%)
Figure 44 CONTRIBTION OF SPINE, BONE HEALING, AND MICROFIXATION SEGMENT TOWARDS COMPANY REVENES, 2011-2013 (SD MN)
Figure 45 MEDTRONIC, PLC. REVENE MIX, 2013 (%)
Figure 46 CONTRIBTION OF RESTORATIVE THERAPIES GROP SEGMENT TOWARDS COMPANY REVENES, 2009-2013 (SD MN)
Figure 47 INTEGRA LIFE SCIENCES CORPORATION REVENE MIX, 2013 (%)
Figure 48 CONTRIBTION OF U.S. SPINE AND OTHER SEGMENT TOWARDS COMPANY REVENES, 2010-2013 (SD MN)
Figure 49 STRYKER CORPORATION REVENE MIX, 2013 (%)
Figure 50 CONTRIBTION OF NEROTECHNOLOGY AND SPINE SEGMENT TOWARDS COMPANY REVENES, 2009-2013 (SD MN)
Figure 51 ZIMMER, INC.: REVENE MIX, 2013 (%)
Figure 52 CONTRIBTION OF SRGICAL AND OTHER SEGMENT TOWARDS COMPANY REVENES, 2009-2013 (SD MN)
Figure 53 DEPY SYNTHES REVENE MIX, 2013 (%)
Figure 54 TORNIER, INC.: REVENE MIX 2013 (%)
Figure 55 CONTRIBTION OF EXTREMITIES SEGMENT TOWARDS COMPANY REVENES, 2009-2013 (SD MN)
Figure 56 NVASIVE, INC.: REVENE MIX 2013 (%)
Figure 57 CONTRIBTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENES, 2009 - 2013 (SD MN)
Figure 58 EXACTECH, INC.: REVENE MIX 2013 (%)
Figure 59 CONTRIBTION OF BIOLOGICS & SPINE SEGMENT TOWARDS COMPANY REVENES, 2009-2013 (SD MN)
Figure 60 GLOBS MEDICAL, INC.: REVENE MIX 2013 (%)
Figure 61 CONTRIBTION OF DISRPTIVE TECHNOLOGY SEGMENT TOWARDS COMPANY REVENES, 2009-2013 (SD MN)
Figure 62 WRIGHT MEDICAL TECHNOLOGY, INC.: REVENE MIX 2013 (%)
Figure 63 CONTRIBTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENES, 2011 - 2013 (SD MN)
